ProUroCare seeks FDA approval for prostate cancer monitoring device

11/29/2009 | Star Tribune (Minneapolis-St. Paul, Minn.)

ProUroCare Medical has submitted an application to the FDA seeking approval for a device that can generate 3-D images of the prostate gland to track prostate cancer. The startup firm said its technology quantifies tissue elasticity to enable physicians to conduct preliminary biopsies and monitor cancer progression.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA